全文获取类型
收费全文 | 2381383篇 |
免费 | 195380篇 |
国内免费 | 4234篇 |
专业分类
耳鼻咽喉 | 34302篇 |
儿科学 | 72946篇 |
妇产科学 | 63077篇 |
基础医学 | 335849篇 |
口腔科学 | 67648篇 |
临床医学 | 216396篇 |
内科学 | 469742篇 |
皮肤病学 | 48064篇 |
神经病学 | 201437篇 |
特种医学 | 96137篇 |
外国民族医学 | 886篇 |
外科学 | 360953篇 |
综合类 | 56328篇 |
现状与发展 | 1篇 |
一般理论 | 989篇 |
预防医学 | 191380篇 |
眼科学 | 55594篇 |
药学 | 178063篇 |
4篇 | |
中国医学 | 4372篇 |
肿瘤学 | 126829篇 |
出版年
2018年 | 24353篇 |
2016年 | 20751篇 |
2015年 | 23479篇 |
2014年 | 33765篇 |
2013年 | 51178篇 |
2012年 | 69208篇 |
2011年 | 72895篇 |
2010年 | 42752篇 |
2009年 | 41149篇 |
2008年 | 69201篇 |
2007年 | 73529篇 |
2006年 | 74418篇 |
2005年 | 72501篇 |
2004年 | 69708篇 |
2003年 | 67414篇 |
2002年 | 66644篇 |
2001年 | 112514篇 |
2000年 | 116575篇 |
1999年 | 98397篇 |
1998年 | 27953篇 |
1997年 | 25594篇 |
1996年 | 25500篇 |
1995年 | 24657篇 |
1994年 | 23215篇 |
1993年 | 21589篇 |
1992年 | 79413篇 |
1991年 | 76419篇 |
1990年 | 73604篇 |
1989年 | 70854篇 |
1988年 | 65865篇 |
1987年 | 64811篇 |
1986年 | 61340篇 |
1985年 | 58408篇 |
1984年 | 44234篇 |
1983年 | 37659篇 |
1982年 | 22901篇 |
1981年 | 20342篇 |
1980年 | 19042篇 |
1979年 | 41304篇 |
1978年 | 28994篇 |
1977年 | 24357篇 |
1976年 | 22838篇 |
1975年 | 23968篇 |
1974年 | 29641篇 |
1973年 | 28045篇 |
1972年 | 26229篇 |
1971年 | 24153篇 |
1970年 | 22752篇 |
1969年 | 21088篇 |
1968年 | 19136篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
ABSTRACTA monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist. 相似文献
62.
63.
64.
65.
66.
67.
68.
69.
70.
Raphael Mohr Robert Schierwagen Carolynne Schwarze-Zander Christoph Boesecke Jan-Christian Wasmuth Jonel Trebicka Jürgen Kurt Rockstroh 《Medicine》2015,94(50)
Liver-related death in human immunodeficiency virus (HIV)-infected individuals is about 10 times higher compared with the general population, and the prevalence of significant liver fibrosis in those with HIV approaches 15%. The present study aimed to assess risk factors for development of hepatic fibrosis in HIV patients receiving a modern combination anti-retroviral therapy (cART).This cross-sectional prospective study included 432 HIV patients, of which 68 (16%) patients were anti-hepatitis C virus (HCV) positive and 23 (5%) were HBsAg positive.Health trajectory including clinical characteristics and liver fibrosis stage assessed by transient elastography were collected at inclusion. Liver stiffness values >7.1 kPa were considered as significant fibrosis, while values >12.5 kPa were defined as severe fibrosis. Logistic regression and Cox regression uni- and multivariate analyses were performed to identify independent factors associated with liver fibrosis.Significant liver fibrosis was detected in 10% of HIV mono-infected, in 37% of HCV co-infected patients, and in 18% of hepatitis B virus co-infected patients. The presence of diabetes mellitus (odds ratio [OR] = 4.6) and FIB4 score (OR = 2.4) were independently associated with presence of significant fibrosis in the whole cohort. Similarly, diabetes mellitus (OR = 5.4), adiposity (OR = 4.6), and the FIB4 score (OR = 3.3) were independently associated with significant fibrosis in HIV mono-infected patients. Importantly, cumulative cART duration protected, whereas persistent HIV viral replication promoted the development of significant liver fibrosis along the duration of HIV infection.Our findings strongly indicate that besides known risk factors like metabolic disorders, HIV may also have a direct effect on fibrogenesis. Successful cART leading to complete suppression of HIV replication might protect from development of liver fibrosis. 相似文献